Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Report
|
Analysis of Zydus Cadila’s corporate history, corporate relationships, biosimilars development pipeline, and Datamonitor's evaluation of the company's strategy and key strengths, weaknesses, opportunities and threats.
Published By Datamonitor
|
06 Jul 2012 |
$3800
|
Report
|
This report aims to explore the opportunities and challenges in the women’s health sector. Market access is evaluated and includes analysis of drug sales, key players, regulatory trends, licensing deals, unmet needs, and marketing strategies.
Published By Datamonitor
|
12 Oct 2011 |
$5700
|
Report
|
Analysis of Watson's corporate strategy and sales performance in 2010 to 2016.
Published By Datamonitor
|
30 Mar 2012 |
$5700
|
Report
|
Analysis of Warner-Chilcott's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016
Published By Datamonitor
|
30 Nov 2011 |
$5700
|
Brief
|
A one stop destination for the latest data and opinion on the US retailer. Aimed at retailers and stakeholders, we analyse Walgreens US business and assess the prospects of its investment in Alliance Boots.
Published By Verdict
|
12 Jul 2012 |
$400
|
Report
|
This report analyzes Vertex’s corporate strategy, sales outlook and financial position through to 2017, supported by in-depth analysis of the company’s key products, driven by patient-based forecasts and key opinion leader interviews.
Published By Datamonitor
|
09 Oct 2012 |
$5700
|
Report
|
This report analyzes the vaccine market in India, and provides recommendations for both local manufacturers operating in the space and Western players looking to enter into this lucrative market.
Published By Datamonitor
|
18 Apr 2012 |
$5700
|
Report
|
While the category 1 vaccine market in China remains dominated by domestic manufacturers, foreign vaccine players are increasing their uptake in the category 2 vaccine market through M&A deals with local companies.
Published By Datamonitor
|
07 Nov 2011 |
$5700
|
Report
|
Datamonitor’s report provides an overview of developments regarding drug regulation, healthcare reform, and intellectual property issues in the US.
Published By Datamonitor
|
15 Nov 2011 |
$1900
|
Report
|
Overview of the US pharmaceutical market including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis and pharmaceutical company infrastructure analysis.
Published By Datamonitor
|
27 Sep 2010 |
$11400
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.